Corporate Information And Statement Of Ifrs Compliance [Abstract]
Concept |
As at 2024-12-31 |
2024-01-01 to 2024-12-31 |
As at 2023-12-31 |
---|---|---|---|
Corporate information and statement of IFRS compliance [abstract] | |||
Name of reporting entity or other means of identification | — |
Onward Medical N.V.
|
— |
Legal form of entity | — |
public limited company
|
— |
Country of incorporation | — |
the Netherlands
|
— |
Description of nature of entity's operations and principal activities | — |
ONWARD and its subsidiaries (the “Group”) are ideveloping and commercializing innovative
|
— |
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
Current inventories |
102,000
EUR
|
— |
–
EUR
|
Current trade payables |
1,269,000
EUR
|
— |
1,369,000
EUR
|
Disclosure of material accounting policy information [text block] | — |
1.5 Summary of Material Accounting Policies
|
— |
Explanation of sources of estimation uncertainty with significant risk of causing material adjustment | — |
1.6 Significant Accounting Judgments, Estimates & Assumptions
|
— |
Disclosure of objectives, policies and processes for managing capital [text block] | — |
Capital Management
|
— |